These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35729055)

  • 1. Consumers' self-reported adherence to directions for non-prescription medicines and the role of risk perception.
    Vong SK; Kang L; Carter SR
    Res Social Adm Pharm; 2022 Nov; 18(11):3929-3938. PubMed ID: 35729055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public risk perception of non-prescription medicines and information disclosure during consultations: a suitable target for intervention?
    Fielding S; Slovic P; Johnston M; Lee AJ; Bond CM; Watson MC
    Int J Pharm Pract; 2018 Oct; 26(5):423-432. PubMed ID: 29318694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of evidence in consumer choice of non-prescription medicines.
    Bevan M; Ng YC; Cooper J; Robertson J; Walkom E; Chiu S; Newby DA
    Int J Pharm Pract; 2019 Dec; 27(6):501-509. PubMed ID: 31140669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of nonprescription medicines by patients with COPD: a survey in Chongqing Municipality, China.
    Cao G; Li J; Li L; Li H; Wang F; Wang H; Zhang L
    Chron Respir Dis; 2012 May; 9(2):77-81. PubMed ID: 22441338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review in select countries of the role of the pharmacist in consultations and sales of non-prescription medicines in community pharmacy.
    van Eikenhorst L; Salema NE; Anderson C
    Res Social Adm Pharm; 2017; 13(1):17-38. PubMed ID: 27033426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General sale of non-prescription medicinal products: Comparing legislation in two European countries.
    Lind J; Schafheutle E; Hägg AN; Sporrong SK
    Res Social Adm Pharm; 2016; 12(1):68-77. PubMed ID: 25842184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receipt and use of spoken and written over-the-counter medicine information: insights into Australian and UK consumers' experiences.
    Tong V; Raynor DK; Aslani P
    Int J Pharm Pract; 2018 Apr; 26(2):129-137. PubMed ID: 28544204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the supply of non-prescription medicines from community pharmacies in Scotland.
    Watson MC; Hart J; Johnston M; Bond CM
    Pharm World Sci; 2008 Oct; 30(5):526-35. PubMed ID: 18297410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic conditions, financial burden and pharmaceutical pricing: insights from Australian consumers.
    Whitty JA; Sav A; Kelly F; King MA; McMillan SS; Kendall E; Wheeler AJ
    Aust Health Rev; 2014 Nov; 38(5):589-95. PubMed ID: 25099307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Australian pharmacists: ready for increased non-prescription medicines reclassification.
    Hope DL; Woods P; Mey A; Kelly FS; Townshend J; Baumann-Birkbeck LM; King MA
    Int J Pharm Pract; 2020 Jun; 28(3):246-254. PubMed ID: 31913550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Widening consumer access to medicines through switching medicines to non-prescription: a six country comparison.
    Gauld NJ; Kelly FS; Kurosawa N; Bryant LJ; Emmerton LM; Buetow SA
    PLoS One; 2014; 9(9):e107726. PubMed ID: 25251434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a questionnaire to measure consumers' perceptions of service quality in community pharmacies.
    Mirzaei A; Carter SR; Chen JY; Rittsteuer C; Schneider CR
    Res Social Adm Pharm; 2019 Apr; 15(4):346-357. PubMed ID: 29903653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-prescription medicines may contribute to non-adherence to prescription medicines in people living with chronic health conditions.
    Anoopkumar-Dukie S; Mey A; Hall S; Bernaitis N; Davey AK; Plummer D
    Int J Clin Pract; 2020 Jun; 74(6):e13489. PubMed ID: 32083362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationales and arguments behind the adoption of self-selection of nonprescription medicines in Denmark.
    Jacobsen SN; Møller-Jensen SE; Sporrong SK
    J Pharm Policy Pract; 2020; 13():29. PubMed ID: 32670593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consumers' preference and willingness to pay for pharmacist counselling for non-prescription medicines.
    Gore PR; Madhavan S
    J Clin Pharm Ther; 1994 Feb; 19(1):17-25. PubMed ID: 8188784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consumer perspectives of medication-related problems following discharge from hospital in Australia: a quantitative study.
    Eassey D; Smith L; Krass I; McLAchlan A; Brien JA
    Int J Qual Health Care; 2016 Jun; 28(3):391-7. PubMed ID: 27118663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the nonprescription drug consumer's understanding of the ranitidine product label and actual product usage patterns in the treatment of episodic heartburn.
    Ciociola AA; Sirgo MA; Pappa KA; McGuire JA; Fung K
    Am J Ther; 2001; 8(6):387-98. PubMed ID: 11704777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality supply of nonprescription medicines in Portuguese community pharmacy: An exploratory case study.
    Veiga P; Lapão LV; Cavaco AM; Guerreiro MP
    Res Social Adm Pharm; 2015; 11(6):880-90. PubMed ID: 25662595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consumer-oriented interventions for evidence-based prescribing and medicines use: an overview of systematic reviews.
    Ryan R; Santesso N; Hill S; Lowe D; Kaufman C; Grimshaw J
    Cochrane Database Syst Rev; 2011 May; (5):CD007768. PubMed ID: 21563160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consumers' willingness to use a medication management service: the effect of medication-related worry and the social influence of the general practitioner.
    Carter SR; Moles RJ; White L; Chen TF
    Res Social Adm Pharm; 2013; 9(4):431-45. PubMed ID: 22999804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.